The US Supreme Court turned away appeals from six pharmaceutical companies seeking to topple the Medicare drug price negotiation program that’s led to billions of dollars in discounts on top-selling treatments.Read More
Drug companies spurned by Supreme Court on price negotiation law
By Greg Stohr
